15 results
8-K
EX-10.1
KA
Kineta Inc
5 Oct 23
Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
Subsidiaries or their financial results or prospects.
(ii)Cybersecurity. (i)(x) There has been no material security breach or other compromise
8-K
EX-10.1
KA
Kineta Inc
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
regarding the Company or its Subsidiaries or their financial results or prospects.
(jj) Cybersecurity. (i)(x) There has been no material security
8-K
EX-99.5
vvsu7jh
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
wjz23
10 Nov 22
Prospectus supplement
4:21pm
8-K
EX-1.1
ji1qd081g3f40mlsa
8 Apr 21
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.1
19gi9j rnbu
15 Dec 20
Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis
7:34am
425
EX-10.1
911n7s b8kgl7bxo9lsa
15 Dec 20
Business combination disclosure
7:32am
- Prev
- 1
- Next